LSTA logo

Lisata Therapeutics (LSTA) Retained Earnings

Annual Retained Earnings

-$528.08 M
-$20.84 M-4.11%

31 December 2023

LSTA Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$543.46 M
-$4.93 M-0.92%

30 September 2024

LSTA Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LSTA Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.1%-4.0%
3 y3 years-24.1%-21.8%
5 y5 years-32.7%-31.8%

LSTA Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-24.1%at low-21.8%at low
5 y5 years-32.7%at low-31.8%at low
alltimeall time<-9999.0%at low<-9999.0%at low

Lisata Therapeutics Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$543.46 M(+0.9%)
June 2024
-
-$538.53 M(+0.9%)
Mar 2024
-
-$533.48 M(+1.0%)
Dec 2023
-$528.08 M(+4.1%)
-$528.08 M(+1.0%)
Sept 2023
-
-$522.72 M(+1.0%)
June 2023
-
-$517.46 M(+0.8%)
Mar 2023
-
-$513.43 M(+1.2%)
Dec 2022
-$507.24 M(+12.0%)
-$507.24 M(+1.2%)
Sept 2022
-
-$501.25 M(+8.1%)
June 2022
-
-$463.87 M(+1.4%)
Mar 2022
-
-$457.24 M(+0.9%)
Dec 2021
-$453.02 M(+6.5%)
-
Dec 2021
-
-$453.02 M(+1.5%)
Sept 2021
-
-$446.22 M(+1.6%)
June 2021
-
-$439.30 M(+1.3%)
Mar 2021
-
-$433.61 M(+1.9%)
Dec 2020
-$425.55 M(+2.0%)
-$425.55 M(+1.3%)
Sept 2020
-
-$420.12 M(+1.3%)
June 2020
-
-$414.79 M(-1.6%)
Mar 2020
-
-$421.39 M(+1.0%)
Dec 2019
-$417.40 M(+4.9%)
-$417.40 M(+1.2%)
Sept 2019
-
-$412.44 M(+1.2%)
June 2019
-
-$407.55 M(+1.3%)
Mar 2019
-
-$402.41 M(+1.1%)
Dec 2018
-$397.98 M(+4.2%)
-$397.98 M(+0.9%)
Sept 2018
-
-$394.42 M(+0.9%)
June 2018
-
-$390.87 M(+1.1%)
Mar 2018
-
-$386.79 M(+1.3%)
Dec 2017
-$381.81 M(-5.7%)
-$381.81 M(+0.8%)
Sept 2017
-
-$378.95 M(+0.9%)
June 2017
-
-$375.43 M(-9.3%)
Mar 2017
-
-$414.15 M(+2.3%)
Dec 2016
-$404.79 M(+8.8%)
-$404.79 M(+1.5%)
Sept 2016
-
-$398.83 M(+1.8%)
June 2016
-
-$391.95 M(+2.0%)
Mar 2016
-
-$384.11 M(+3.2%)
Dec 2015
-$372.13 M(+27.8%)
-$372.13 M(+9.8%)
Sept 2015
-
-$338.94 M(+3.5%)
June 2015
-
-$327.56 M(+5.5%)
Mar 2015
-
-$310.43 M(+6.6%)
Dec 2014
-$291.25 M(+23.2%)
-$291.25 M(+4.2%)
Sept 2014
-
-$279.63 M(+6.5%)
June 2014
-
-$262.66 M(+5.0%)
Mar 2014
-
-$250.06 M(+5.8%)
Dec 2013
-$236.37 M(+19.7%)
-$236.37 M(+5.6%)
Sept 2013
-
-$223.84 M(+4.2%)
June 2013
-
-$214.77 M(+4.2%)
Mar 2013
-
-$206.19 M(+4.5%)
Dec 2012
-$197.39 M(+37.9%)
-$197.39 M(+8.7%)
Sept 2012
-
-$181.62 M(+4.9%)
June 2012
-
-$173.14 M(+13.5%)
Mar 2012
-
-$152.55 M(+6.6%)
DateAnnualQuarterly
Dec 2011
-$143.09 M(+50.1%)
-$143.09 M(+15.3%)
Sept 2011
-
-$124.12 M(+6.6%)
June 2011
-
-$116.46 M(+10.2%)
Mar 2011
-
-$105.68 M(+10.9%)
Dec 2010
-$95.32 M(+32.8%)
-$95.32 M(+7.1%)
Sept 2010
-
-$88.98 M(+8.7%)
June 2010
-
-$81.84 M(+7.1%)
Mar 2010
-
-$76.39 M(+6.4%)
Dec 2009
-$71.78 M(+79.5%)
-$71.78 M(+31.9%)
Sept 2009
-
-$54.43 M(+16.3%)
June 2009
-
-$46.80 M(+11.8%)
Mar 2009
-
-$41.86 M(+4.7%)
Dec 2008
-$39.99 M(+30.1%)
-$39.99 M(+6.5%)
Sept 2008
-
-$37.56 M(+5.4%)
June 2008
-
-$35.64 M(+7.1%)
Mar 2008
-
-$33.28 M(+8.2%)
Dec 2007
-$30.75 M(+51.4%)
-$30.75 M(+8.2%)
Sept 2007
-
-$28.41 M(+18.0%)
June 2007
-
-$24.08 M(+8.9%)
Mar 2007
-
-$22.12 M(+8.9%)
Dec 2006
-$20.31 M(+42.4%)
-$20.31 M(+10.1%)
Sept 2006
-
-$18.45 M(+10.9%)
June 2006
-
-$16.64 M(+8.1%)
Mar 2006
-
-$15.39 M(+8.0%)
Dec 2005
-$14.26 M(+13.9%)
-$14.26 M(+3.8%)
Sept 2005
-
-$13.73 M(+4.4%)
June 2005
-
-$13.15 M(+3.1%)
Mar 2005
-
-$12.76 M(+2.0%)
Dec 2004
-$12.51 M(+16.2%)
-$12.51 M(+2.5%)
Sept 2004
-
-$12.21 M(+4.3%)
June 2004
-
-$11.71 M(+4.4%)
Mar 2004
-
-$11.22 M(+4.2%)
Dec 2003
-$10.76 M(+11.0%)
-$10.76 M(+4.2%)
Sept 2003
-
-$10.32 M(+2.1%)
June 2003
-
-$10.11 M(+2.6%)
Mar 2003
-
-$9.85 M(+1.6%)
Dec 2002
-$9.69 M(+14.2%)
-$9.69 M(+4.2%)
Sept 2002
-
-$9.31 M(+2.5%)
June 2002
-
-$9.07 M(+2.8%)
Mar 2002
-
-$8.83 M(+4.0%)
Dec 2001
-$8.49 M(+32.5%)
-$8.49 M(+9.3%)
Sept 2001
-
-$7.76 M(+5.1%)
June 2001
-
-$7.39 M(+4.8%)
Mar 2001
-
-$7.05 M(+10.0%)
Dec 2000
-$6.41 M(+47.9%)
-$6.41 M(+9.3%)
Sept 2000
-
-$5.86 M(+19.3%)
June 2000
-
-$4.91 M(+8.4%)
Mar 2000
-
-$4.53 M
Dec 1999
-$4.33 M(+37.0%)
-
Dec 1998
-$3.16 M(+16.5%)
-
Mar 1998
-$2.71 M(+10.8%)
-
Mar 1997
-$2.45 M(+15.7%)
-
Mar 1996
-$2.12 M
-

FAQ

  • What is Lisata Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Lisata Therapeutics?
  • What is Lisata Therapeutics annual retained earnings year-on-year change?
  • What is Lisata Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly retained earnings year-on-year change?

What is Lisata Therapeutics annual retained earnings?

The current annual retained earnings of LSTA is -$528.08 M

What is the all time high annual retained earnings for Lisata Therapeutics?

Lisata Therapeutics all-time high annual retained earnings is -$2.12 M

What is Lisata Therapeutics annual retained earnings year-on-year change?

Over the past year, LSTA annual retained earnings has changed by -$20.84 M (-4.11%)

What is Lisata Therapeutics quarterly retained earnings?

The current quarterly retained earnings of LSTA is -$543.46 M

What is the all time high quarterly retained earnings for Lisata Therapeutics?

Lisata Therapeutics all-time high quarterly retained earnings is -$4.53 M

What is Lisata Therapeutics quarterly retained earnings year-on-year change?

Over the past year, LSTA quarterly retained earnings has changed by -$20.74 M (-3.97%)